PUBLIC CONTRACT · 2023
Sacituzumab govitecano 200 mg pó conc sol inj fr IV
- Contract value
- €301,000.00
- Signed on
- 3 January 2023
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9934685PUBLISHED SUBJECT
SACITUZUMAB GOVITECANO 200 MG PÓ CONC SOL INJ FR IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Almada
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES LDA. · Tax ID 503604704
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €301,000.00
- Procedure base price
- €301,000.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 18 April 2023
- Award date
- 3 January 2023
- Signing date
- 3 January 2023
- Performance period
- 366 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6452005
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.